Da Wei Ma
Direttore/Membro del Consiglio presso SHANGHAI MEDICILON INC.
Provenienza dei contatti di primo grado di Da Wei Ma
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 15 | |
Shanghai Weishen Pharmaceutical Co., Ltd.
Shanghai Weishen Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Weishen Pharmaceutical Co., Ltd. is a company founded in 2019 that specializes in the research, development, production, sale, and service of pharmaceutical machinery. The company is based in Shanghai, China. The Chinese company focuses on scientific and technological innovation to serve the pharmaceutical industry with advanced technology. The company has a professional installation team with a minimum of 6 years of experience, possessing strong practical hands-on problem-solving capabilities. The company aims to improve the production standard and maximize investment benefits through effective training.
5
| Holding Company | Biotechnology | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Da Wei Ma tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Medicilon Puhui Pharmaceutical Technology (Shanghai) Co. Ltd.
Medicilon Puhui Pharmaceutical Technology (Shanghai) Co. Ltd. Real Estate DevelopmentFinance Medicilon Puhui Pharmaceutical Technology (Shanghai) Co. Ltd, engages in the import and export of goods and technology. Its business scope includes technical services and consultation, technology development and transfer of pharmaceutical technology, biotechnology, and chemical technology; and sales of the first and second type of medical equipment. The company was founded on November 29, 2007 and is headquartered in Shanghai, China. | Real Estate Development | Director/Board Member Director/Board Member | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bay Environmental Technology (Beijing) Corp.
Bay Environmental Technology (Beijing) Corp. Oil & Gas ProductionEnergy Minerals Bay Environmental Technology (Beijing) Corp. operates as an environmental protection service company. It specializes in volatile organic compounds treatment, vapor recovery system, PM2.5 treatment and low-nitrogen combustion, devotes us in providing complete environmental protection schemes to petrochemical industries and industrial enterprises. The company was founded by Wei Wei on July 12, 1994 and is headquartered in Beijing, China. | Oil & Gas Production | Director/Board Member | |
KEHUA HOLDINGS CO.,LTD | Auto Parts: OEM | Director/Board Member | |
JIANGSU EASTERN SHENGHONG CO.,LTD. | Electric Utilities | Director/Board Member | |
FUJIAN FYNEX TEXTILE SCIENCE & TECHNOLOGY CO., LTD. | Textiles | Director/Board Member | |
Yestar Aesthetic Medical Group Co., Ltd.
Yestar Aesthetic Medical Group Co., Ltd. Hospital/Nursing ManagementHealth Services Yestar Aesthetic Medical Group Co., Ltd. engages in the provision of aesthetic medical services. It focuses on surgery and dermatology services. The company was founded by Guo Xing Chen and Guo Xion Chen on October 14, 2009 and is headquartered in Hangzhou, China. | Hospital/Nursing Management | Founder | |
Shaanxi Master of Business Administration Institute | College/University | Graduate Degree | |
China State Institute of Pharmaceutical Industry
China State Institute of Pharmaceutical Industry Pharmaceuticals: MajorHealth Technology China State Institute of Pharmaceutical Industry regulates pharmaceutical companies. The company is based in Shanghai, China. The Chinese company is a subsidiary ultimately controlled by the Government of China. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sichuan Industrial Institute of Antibiotics | College/University | Director/Board Member | |
Sinopharm Holding Co., Ltd.
Sinopharm Holding Co., Ltd. Financial ConglomeratesFinance Part of Sinopharm Industrial Investment Co., Ltd., Sinopharm Holding Co., Ltd. functions as an investment holding Chinese company. The company is based in Haicang District, Hong Kong. | Financial Conglomerates | Corporate Officer/Principal | |
China Pharmaceutical University | College/University | Doctorate Degree | |
BOILL HEALTHCARE HOLDINGS LIMITED | Real Estate Development | Director/Board Member | |
Shanghai Pudong Science & Technology Investment Co. Ltd.
Shanghai Pudong Science & Technology Investment Co. Ltd. Investment ManagersFinance Shanghai Pudong Science & Technology Investment Co. Ltd. (PDSTI) is an independent Shanghai private equity and venture capital investment firm which was established in 1999, specializing in high-tech industries investments and M&A opportunities. Based in Shanghai, the firm focuses on the investment of integrated circuit, healthcare and other high-tech industries, and forms an experienced and professional team in M&A investment (domestic and cross-border), equity investments and other investment fields. PDSTI aims to commit itself to integrate the global high-tech industry resources, and enhance the corporate value, in order to portray itself as a global, dynamic and competitive world-class investment institution. | Investment Managers | Director/Board Member | |
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd.
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. BiotechnologyHealth Technology Part of Hepagene Therapeutics, Inc., Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese company that engages in research and development of new drugs. The company is based in Shanghai, China. The company was founded in 2016 by Xiao Dong Xu. | Biotechnology | Director/Board Member | |
Shenzhen Hua Xia Ren He Capital Management Co., Ltd.
Shenzhen Hua Xia Ren He Capital Management Co., Ltd. Investment ManagersFinance Shenzhen Hua Xia Ren He Capital Management Co., Ltd. engages in asset management services. Its business also include equity investment, investment management, investment advice, enterprise management and consulting, and marketing planning. The company was founded on December 28, 2012 and is headquartered in Shenzhen, China. | Investment Managers | Chief Executive Officer | |
Oklahoma State University | College/University | Doctorate Degree | |
Bellen Chemistry Co., Ltd.
Bellen Chemistry Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bellen Chemistry Co., Ltd. provides contract chemistry services. It offers chemical synthesis contract development and manufacturing organization (CDMO) services, chemical synthesis contract research organization (CRO) services, and drug molecular building blocks. The company was founded by Bo Liu, Li Xin Xing, Jian Hua Ren, Jian Xun Liu, and Yong Jun Jiang on January 28, 2010 and is headquartered in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member | |
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Sinovent Pharmaceutical Technology Co. Ltd. is a private company that focuses on researching, developing, producing, and commercializing therapeutic drugs. The company is based in Suzhou, China. | Miscellaneous Commercial Services | Director/Board Member | |
CITIC SECURITIES COMPANY LIMITED | Investment Banks/Brokers | Corporate Officer/Principal | |
Shanghai Xingze Xinghe Investment Management Center | Corporate Officer/Principal | ||
Shanghai Yueyi Investment Center | Chief Investment Officer | ||
Peking Union Medical College | College/University | Doctorate Degree | |
SINOMAB BIOSCIENCE LIMITED | Biotechnology | Director/Board Member | |
China International Capital Corp. Ltd. (Broker)
China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Investment Banks/Brokers | Analyst-Equity | |
Fudan University | College/University | Undergraduate Degree | |
Hangzhou Guangren Hospital Co. Ltd. | Corporate Officer/Principal | ||
Nanjing University | College/University | Director/Board Member | |
SHANGHAI COOLTECH POWER CO., LTD. | Electrical Products | Director/Board Member |
Statistiche
Distribuzione geografica
Cina | 26 |
Stati Uniti | 3 |
Hong Kong | 3 |
Settori
Finance | 8 |
Consumer Services | 8 |
Health Technology | 5 |
Producer Manufacturing | 3 |
Commercial Services | 3 |
Posizioni
Director/Board Member | 31 |
Independent Dir/Board Member | 8 |
Corporate Officer/Principal | 7 |
Chairman | 4 |
Founder | 3 |
Contatti più connessi
Insiders | |
---|---|
Hai Gang Chen | 10 |
Ba Xian Yi | 8 |
Chun Lin Chen | 4 |
Jin Ye Xu | 4 |
Zhang Qing Lin | 3 |
Wei Chun Jin | 3 |
Wei Dong Lai | 2 |
Jin Zhang Chen | 2 |
Xian Cheng Zeng | 2 |
Guo Xing Chen | 2 |
Bin Bin Liu | 1 |
Jian Huang Chen | 1 |
Jin Na Cai | 1 |
Chao Xue | 1 |
Nan Zhuo | 1 |
- Borsa valori
- Insiders
- Da Wei Ma
- Connessioni Società